Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding

Arch Dis Child Fetal Neonatal Ed. 2012 May;97(3):F214-6. doi: 10.1136/adc.2009.178723. Epub 2010 Jul 23.

Abstract

It is widely accepted that maternal drug-exposed infants demonstrate excessive early weight loss, but this has not previously been quantified. Among 354 term, substitute methadone-exposed infants, median maximal weight losses were 10.2% and 8.5% for breast- and formula-fed infants, respectively (p=0.003). Weight loss was less in small for gestational age compared to appropriately grown infants (p<0.001). There was no association between maximal weight loss and plasma sodium concentration (p=0.807). Relative to non-drug exposed infants, weight loss was more marked in formula-fed infants, 48% of whom demonstrated weight loss in excess of the 95th centile (compared to 23% of exclusively breastfed infants; p<0.001). Median weight loss nadir was on day 5, excepting those infants exclusively breastfed (day 4). These data suggest that excessive neonatal weight loss among breastfed infants of drug-misusing mothers does not necessarily reflect poorly established lactation and may help to guide management of breast feeding in this population.

MeSH terms

  • Adolescent
  • Adult
  • Birth Weight
  • Bottle Feeding
  • Breast Feeding*
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Methadone / pharmacology*
  • Methadone / therapeutic use
  • Neonatal Abstinence Syndrome / physiopathology
  • Opiate Substitution Treatment*
  • Opioid-Related Disorders / rehabilitation
  • Pregnancy
  • Pregnancy Complications
  • Retrospective Studies
  • Sodium / blood
  • Weight Loss / drug effects*
  • Weight Loss / physiology
  • Young Adult

Substances

  • Sodium
  • Methadone